Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 18

1.

Proton magnetic resonance spectroscopy revealed choline reduction in the visual cortex in an experimental model of chronic glaucoma.

Chan KC, So KF, Wu EX.

Exp Eye Res. 2009 Jan;88(1):65-70. doi: 10.1016/j.exer.2008.10.002. Epub 2008 Nov 1.

PMID:
18992243
2.

Magnetic resonance in studies of glaucoma.

Fiedorowicz M, Dyda W, Rejdak R, Grieb P.

Med Sci Monit. 2011 Oct;17(10):RA227-32. Review.

3.

Molecular characterization of musculoskeletal tumors by proton MR spectroscopy.

Fayad LM, Barker PB, Bluemke DA.

Semin Musculoskelet Radiol. 2007 Sep;11(3):240-5. doi: 10.1055/s-2008-1038313. Review.

PMID:
18260034
4.

Magnetic resonance spectroscopy in animal models of epilepsy.

Hiremath GK, Najm IM.

Epilepsia. 2007;48 Suppl 4:47-55. Review.

5.

Human fetal brain chemistry as detected by proton magnetic resonance spectroscopy.

Brighina E, Bresolin N, Pardi G, Rango M.

Pediatr Neurol. 2009 May;40(5):327-42. doi: 10.1016/j.pediatrneurol.2008.11.001. Review.

PMID:
19380068
6.

In vivo multiparametric magnetic resonance imaging and spectroscopy of rodent visual system.

Chan KC, Cheung MM, Wu EX.

J Integr Neurosci. 2010 Dec;9(4):477-508. Review.

PMID:
21213415
7.

Complications in major depressive disorder therapy: a review of magnetic resonance spectroscopy studies.

Caverzasi E, Pichiecchio A, Calligaro A, Pasin M, Giugni E, Pasquini M, Biondi M, Barale F, Bastianello S.

Funct Neurol. 2008 Jul-Sep;23(3):129-32. Review.

PMID:
19152732
8.

Advances in neuroimaging of the visual pathways and their use in glaucoma.

Garaci FG, Cozzolino V, Nucci C, Gaudiello F, Ludovici A, Lupattelli T, Floris R, Simonetti G.

Prog Brain Res. 2008;173:165-77. doi: 10.1016/S0079-6123(08)01112-6. Review.

PMID:
18929108
9.

Glaucoma of the brain: a disease model for the study of transsynaptic neural degeneration.

YĆ¼cel Y, Gupta N.

Prog Brain Res. 2008;173:465-78. doi: 10.1016/S0079-6123(08)01132-1. Review.

PMID:
18929128
10.

Multinuclear magnetic resonance spectroscopy for in vivo assessment of mitochondrial dysfunction in Parkinson's disease.

Henchcliffe C, Shungu DC, Mao X, Huang C, Nirenberg MJ, Jenkins BG, Beal MF.

Ann N Y Acad Sci. 2008 Dec;1147:206-20. doi: 10.1196/annals.1427.037. Review.

PMID:
19076443
11.

MR spectroscopy in diagnosis and neurological decision-making.

Xu V, Chan H, Lin AP, Sailasuta N, Valencerina S, Tran T, Hovener J, Ross BD.

Semin Neurol. 2008 Sep;28(4):407-22. doi: 10.1055/s-0028-1083685. Epub 2008 Oct 8. Review.

PMID:
18843570
12.
13.

[The application and research progress of functional magnetic resonance imaging in glaucoma].

Yang HF, Liu TT, Sun XH.

Zhonghua Yan Ke Za Zhi. 2013 Nov;49(11):1040-4. Review. Chinese.

PMID:
24555211
14.

[Functional magnetic resonance imaging in glaucoma].

Chen ZQ, Gao J, Zhang H.

Zhonghua Yan Ke Za Zhi. 2012 Nov;48(11):1045-8. Review. Chinese.

PMID:
23302279
15.

Immunological mechanisms in glaucoma.

Grus F, Sun D.

Semin Immunopathol. 2008 Apr;30(2):121-6. doi: 10.1007/s00281-008-0105-8. Epub 2008 Mar 11. Review.

PMID:
18330572
16.

Choline metabolism in malignant transformation.

Glunde K, Bhujwalla ZM, Ronen SM.

Nat Rev Cancer. 2011 Nov 17;11(12):835-48. doi: 10.1038/nrc3162. Review.

17.

Using magnetic resonance imaging to assess visual deficits: a review.

Brown HD, Woodall RL, Kitching RE, Baseler HA, Morland AB.

Ophthalmic Physiol Opt. 2016 May;36(3):240-65. doi: 10.1111/opo.12293. Review.

18.

EXPERIMENTAL HEMOCHROMATOSIS IN THE RAT.

MAYER J.

Nutr Rev. 1965 Jun;23:189-91. Review. No abstract available.

PMID:
14327827

Supplemental Content

Support Center